World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
42460
World Ranking
6005
National Ranking
3211

Stephen J. Freedland publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stephen J. Freedland sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,236 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stephen J. Freedland D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen J. Freedland sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2021 - Member of the American Society for Clinical Investigation
  • 2020 - Member of the American Society for Clinical Investigation
  • 2019 - Member of the American Society for Clinical Investigation
  • 2018 - Member of the American Society for Clinical Investigation
  • 2017 - Member of the American Society for Clinical Investigation
  • 2016 - Member of the American Society for Clinical Investigation
  • 2015 - Member of the American Society for Clinical Investigation
  • 2014 - Member of the American Society for Clinical Investigation
  • 2013 - Member of the American Society for Clinical Investigation
  • 2012 - Member of the American Society for Clinical Investigation
  • 2011 - Member of the American Society for Clinical Investigation
  • 2010 - Member of the American Society for Clinical Investigation
  • 2009 - Member of the American Society for Clinical Investigation
  • 2008 - Member of the American Society for Clinical Investigation
  • 2007 - Member of the American Society for Clinical Investigation
  • 2006 - Member of the American Society for Clinical Investigation
  • 2005 - Member of the American Society for Clinical Investigation
  • 2004 - Member of the American Society for Clinical Investigation
  • 2003 - Member of the American Society for Clinical Investigation
  • 2002 - Member of the American Society for Clinical Investigation
  • 2001 - Member of the American Society for Clinical Investigation
  • 2000 - Member of the American Society for Clinical Investigation
  • 1999 - Member of the American Society for Clinical Investigation
  • 1998 - Member of the American Society for Clinical Investigation
  • 1997 - Member of the American Society for Clinical Investigation
  • 1996 - Member of the American Society for Clinical Investigation
  • 1995 - Member of the American Society for Clinical Investigation
  • 1994 - Member of the American Society for Clinical Investigation
  • 1993 - Member of the American Society for Clinical Investigation
  • 1992 - Member of the American Society for Clinical Investigation
  • 1991 - Member of the American Society for Clinical Investigation
  • 1990 - Member of the American Society for Clinical Investigation
  • 1989 - Member of the American Society for Clinical Investigation
  • 1988 - Member of the American Society for Clinical Investigation
  • 1987 - Member of the American Society for Clinical Investigation
  • 1986 - Member of the American Society for Clinical Investigation
  • 1985 - Member of the American Society for Clinical Investigation
  • 1984 - Member of the American Society for Clinical Investigation
  • 1983 - Member of the American Society for Clinical Investigation
  • 1982 - Member of the American Society for Clinical Investigation

Overview

Stephen J. Freedland is affiliated with Cedars-Sinai Medical Center in the United States. Their research primarily focuses on medicine, with significant contributions across various subfields including pulmonary and respiratory medicine, oncology, cancer research, surgery, and radiology, nuclear medicine, and imaging.

The scientist's work extensively covers prostate cancer, demonstrated by the main topics they have published on: prostate cancer treatment and research, prostate cancer diagnosis and treatment, cancer, lipids, and metabolism, radiopharmaceutical chemistry and applications, bladder and urothelial cancer treatments, hormonal and reproductive studies, and statistical methods in clinical trials.

Freedland has authored numerous papers, with notable recent publications including:

  • Epidemiology and Prevention of Prostate Cancer, 2021, European Urology Oncology
  • Epidemiology and Genomics of Prostate Cancer in Asian Men, 2021, Nature Reviews Urology
  • Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer, 2023, New England Journal of Medicine
  • A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer, 2020, European Urology
  • Survival of African-American and Caucasian Men after Sipuleucel-T Immunotherapy: Outcomes from the PROCEED Registry, 2020, Prostate Cancer and Prostatic Diseases

Freedland frequently publishes in a range of venues, with the highest number of publications appearing in:

  • The Journal of Urology
  • Journal of Clinical Oncology
  • Prostate Cancer and Prostatic Diseases
  • Urologic Oncology Seminars and Original Investigations
  • European Urology

Regular co-authors who have collaborated extensively with Freedland include Amanda M. De Hoedt, Zachary Klaassen, Lauren E. Howard, Matthew R. Cooperberg, and William J. Aronson.

Over the years, Freedland has received recognition as a member of the American Society for Clinical Investigation consistently from 1982 through 2021, reflecting a longstanding engagement with the clinical research community.

Best Publications

  • Early detection of prostate cancer: AUA Guideline

    H. Ballentine Carter;Peter C. Albertsen;Michael J. Barry;Ruth Etzioni

  • Autonomic nerve development contributes to prostate cancer progression.

    Claire Magnon;Simon J. Hall;Juan Lin;Xiaonan Xue

  • Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

    Martin G. Sanda;Jeffrey A. Cadeddu;Erin Kirkby;Ronald C. Chen

  • Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy

    Bruce J. Trock;Misop Han;Stephen J. Freedland;Elizabeth B. Humphreys

  • Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

    Nancy L. Keating;A. James O'Malley;Stephen J. Freedland;Matthew R. Smith

  • Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study Group

    Stephen J. Freedland;William J. Aronson;Christopher J. Kane;Joseph C. Presti

  • Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.

    Carmen Rodriguez;Stephen J Freedland;Anusila Deka;Eric J Jacobs

  • The Correlation Between Metabolic Syndrome and Prostatic Diseases

    Cosimo De Nunzio;William Aronson;Stephen J. Freedland;Edward Giovannucci

  • Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.

    Lionel L. Bañez;Robert J. Hamilton;Robert J. Hamilton;Alan W. Partin;Robin T. Vollmer

  • Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology.

    Philipp Nuhn;Johann S. De Bono;Karim Fizazi;Stephen J. Freedland;Stephen J. Freedland

  • The Contemporary Concept of Significant Versus Insignificant Prostate Cancer

    Guillaume Ploussard;Jonathan I. Epstein;Rodolfo Montironi;Rodolfo Montironi;Peter R. Carroll

  • Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options

    Martin G. Sanda;Jeffrey A. Cadeddu;Erin Kirkby;Ronald C. Chen

  • Association of Black Race with Prostate Cancer-Specific and Other-Cause Mortality

    Robert T. Dess;Holly E. Hartman;Brandon A. Mahal;Payal D. Soni

  • Epidemiology and Prevention of Prostate Cancer.

    Giorgio Gandaglia;Riccardo Leni;Freddie Bray;Neil Fleshner

  • Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction

    Lee W Jones;Neil D Eves;Mark Haykowsky;Stephen J Freedland

  • Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy

    Stephen J Freedland;Mark E Sutter;Frederick Dorey;William J Aronson;William J Aronson

  • Castration-Resistant Prostate Cancer: AUA Guideline

    Michael S. Cookson;Bruce J. Roth;Philipp Dahm;Christine Engstrom

  • Obesity and Prostate Cancer: Making Sense out of Apparently Conflicting Data

    Stephen J. Freedland;Stephen J. Freedland;Elizabeth A. Platz

  • Prostate Size and Risk of High-Grade, Advanced Prostate Cancer and Biochemical Progression After Radical Prostatectomy: A Search Database Study

    Stephen J. Freedland;William B. Isaacs;Elizabeth A. Platz;Martha Kennedy Terris

  • Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.

    Shuang G. Zhao;S. Laura Chang;Nicholas Erho;Menggang Yu

Frequent Co-Authors

William J. Aronson
William J. Aronson University of California, Los Angeles
Martha K. Terris
Martha K. Terris Augusta University
Christopher J. Kane
Christopher J. Kane University of California, San Diego
Matthew R. Cooperberg
Matthew R. Cooperberg University of California, San Francisco
Gerald L. Andriole
Gerald L. Andriole Washington University in St. Louis
Leah Gerber
Leah Gerber Duke University
Alan W. Partin
Alan W. Partin Johns Hopkins University School of Medicine
Judd W. Moul
Judd W. Moul Duke University
Thomas J. Polascik
Thomas J. Polascik Duke University
Edward M. Schaeffer
Edward M. Schaeffer Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but considering alternative routes to a medical degree, there are several accredited online programs worth exploring. Nursing remains a popular and flexible career path, with online options making it more accessible than ever.

Many students are attracted to the cheapest online accelerated bsn programs, which allow individuals with a non-nursing bachelor’s degree to enter the field efficiently and affordably. For registered nurses aiming to enhance their qualifications, cheap rn to bsn online programs provide a flexible way to earn a bachelor’s degree while continuing to work.

Advanced practice and leadership roles can be achieved via online nursing doctoral programs, supporting those interested in research, education, or executive positions. If you're coming from a completely different field, direct entry msn programs for non-nurses online enable career changers to begin a nursing career through an accelerated, graduate-level pathway.

These online options offer flexibility and may lower costs, making them appealing choices for those seeking alternative or supplementary healthcare careers in the US.

Best Scientists Citing Stephen J. Freedland

Trending Scientists

Recently Published Articles